224
Views
4
CrossRef citations to date
0
Altmetric
Perspective

Hormonal therapies in migraine management: current perspectives on patient selection and risk management

ORCID Icon, ORCID Icon, , , , , & ORCID Icon show all
Pages 1347-1355 | Received 03 Aug 2021, Accepted 04 Nov 2021, Published online: 25 Nov 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lara Tiranini, Laura Cucinella, Silvia Martella, David Bosoni, Ellis Martini & Rossella E. Nappi. (2023) Is now the time to reconsider risks, benefits, and limitations of estrogen preparations as a treatment for menstrually related migraine?. Expert Review of Neurotherapeutics 23:4, pages 377-388.
Read now

Articles from other publishers (3)

Dilara Onan, William David Wells-Gatnik, Enrico Bentivegna, Christian Lampl & Paolo Martelletti. (2023) New Migraine Drugs for Older Adults. Drugs & Aging 40:4, pages 301-305.
Crossref
Alessia Filippone, Sarah Adriana Scuderi, Rossella Basilotta, Marika Lanza, Giovanna Casili, Valentina Bova, Irene Paterniti & Emanuela Esposito. (2022) BAY-117082-driven NLRP3 inflammasome inhibition resolves nitro-glycerine (NTG) neuronal damage in in vivo model of migraine. Biomedicine & Pharmacotherapy 156, pages 113851.
Crossref
Joy-Fleur van der Vaart & Gabriele Susanne Merki-Feld. (2022) Sex hormone-related polymorphisms in endometriosis and migraine: A narrative review. Women's Health 18, pages 174550572211113.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.